[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
[ Wed, May 15th 2024 ]: WOPRAI
Serge Belanger Maintained (ARQT) at Strong Buy with Increased Target to $18 on, May 15th, 2024
- 🞛 This publication is a summary or evaluation of another publication
Serge Belanger of Needham, Maintained "Arcutis Biotherapeutics, Inc." (ARQT) at Strong Buy with Increased Target from $16 to $18 on, May 15th, 2024.
Serge has made no other calls on ARQT in the last 4 months.
There is 1 other peer that has a rating on ARQT. Out of the 1 peers that are also analyzing ARQT, all agrees with Serge's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jonathan Block of "Goldman Sachs" Maintained at Hold with Increased Target to $11 on, Wednesday, February 28th, 2024